Olibra was developed from a natural fat extract that triggers the release of chemicals that make the brain think the stomach is full. Scotia launched Olibra in January when it went on sale in Sweden as the key ingredient of Maval yoghurt, in partnership with the Swedish food group Skanemejerier. Since its launch, Maval has won 2 per cent of the Swedish fruit yoghurt market and Scotia now plans to introduce Olibra to consumers around the world.
Olibra is being introduced in the UK under the brand name Skane Dairy Maval in an initial deal between Safeway and Skanemejerier. It is likely to be extended to other supermarkets by the end of the year.
Scotia also announced that it is trimming its product portfolio from 20 drugs to five. It is concentrating on cancer treatments which could be an alternative to chemotherapy.